SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Sheng-Jie Wu, Gui-Qi Zhu, Bo-Zhi Ye, Fan-Qi Kong, Zai-Xing Zheng, Hai Zou, Ke-Qing Shi, Lu Lin, Martin Braddock, Wei-Jian Huang, Yong-Ping Chen, Ming-Hua Zheng, Association Between Sex-Specific Serum Uric Acid and Non-Alcoholic Fatty Liver Disease in Chinese Adults, Medicine, 2015, 94, 17, e802

    CrossRef

  2. 2
    Dvir Froylich, Ricard Corcelles, Christopher Daigle, Mena Boules, Stacy Brethauer, Philip Schauer, Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study, Surgery for Obesity and Related Diseases, 2015,

    CrossRef

  3. 3
    M. Pilar Valdecantos, Pedro Luis Prieto-Hontoria, Virginia Pardo, Teresa Módol, Beatriz Santamaría, Minéia Weber, Laura Herrero, Dolors Serra, Jordi Muntané, Antonio Cuadrado, María Jesús Moreno-Aliaga, J. Alfredo Martínez, Ángela M. Valverde, Essential role of Nrf2 in the protective effect of lipoic acid against lipoapoptosis in hepatocytes, Free Radical Biology and Medicine, 2015, 84, 263

    CrossRef

  4. 4
    Hao Han, Hongfei Ma, Shuang Rong, Li Chen, Zhilei Shan, Jiqu Xu, Yunjian Zhang, Liegang Liu, Flaxseed oil containing flaxseed oil ester of plant sterol attenuates high-fat diet-induced hepatic steatosis in apolipoprotein-E knockout mice, Journal of Functional Foods, 2015, 13, 169

    CrossRef

  5. 5
    Sheng-Jie Wu, Hai Zou, Gui-Qi Zhu, Li-Ren Wang, Qi Zhang, Ke-Qing Shi, Ji-Bo Han, Wei-Jian Huang, Martin Braddock, Yong-Ping Chen, Ming-Hua Zheng, Increased Levels of Systolic Blood Pressure Within the Normal Range Are Associated With Significantly Elevated Risks of Nonalcoholic Fatty Liver Disease, Journal of Pediatric Gastroenterology and Nutrition, 2015, 94, 19, 1

    CrossRef

  6. 6
    Chandrashekhar R. Gandhi, J. Richard Chaillet, Michael A. Nalesnik, Sudhir Kumar, Anil Dangi, A. Jake Demetris, Robert Ferrell, Tong Wu, Senad Divanovic, Traci Stankeiwicz, Benjamin Shaffer, Donna B. Stolz, Stephen A.K. Harvey, Jiang Wang, Thomas E. Starzl, Liver-Specific Deletion of Augmenter of Liver Regeneration Accelerates Development of Steatohepatitis and Hepatocellular Carcinoma in Mice, Gastroenterology, 2015, 148, 2, 379

    CrossRef

  7. 7
    Jun Han, Na Yang, Feng Zhang, Chuan Zhang, Fengying Liang, WeiFen Xie, Wansheng Chen, Rhizoma Anemarrhenae extract ameliorates hyperglycemia and insulin resistance via activation of AMP-activated protein kinase in diabetic rodents, Journal of Ethnopharmacology, 2015, 172, 368

    CrossRef

  8. 8
    Lindsei K. Sarna, Yaw L. Siow, Karmin O, The CBS/CSE system: a potential therapeutic target in NAFLD?, Canadian Journal of Physiology and Pharmacology, 2015, 93, 1, 1

    CrossRef

  9. 9
    Emily S. Koeck, Tatiana Iordanskaia, Samantha Sevilla, Sarah C. Ferrante, Monica J. Hubal, Robert J. Freishtat, Evan P. Nadler, Adipocyte exosomes induce transforming growth factor beta pathway dysregulation in hepatocytes: a novel paradigm for obesity-related liver disease, Journal of Surgical Research, 2014, 192, 2, 268

    CrossRef

  10. 10
    Natsumi Maehara, Satoko Arai, Mayumi Mori, Yoshihiro Iwamura, Jun Kurokawa, Toshihiro Kai, Shunsuke Kusunoki, Kaori Taniguchi, Kazutaka Ikeda, Osamu Ohara, Ken-ichi Yamamura, Toru Miyazaki, Circulating AIM Prevents Hepatocellular Carcinoma through Complement Activation, Cell Reports, 2014, 9, 1, 61

    CrossRef

  11. 11
    Sandy Feng, Jennifer C. Lai, Expanded Criteria Donors, Clinics in Liver Disease, 2014, 18, 3, 633

    CrossRef

  12. 12
    Sandra Winkler, Erawan Borkham-Kamphorst, Peggy Stock, Sandra Brückner, Matthias Dollinger, Ralf Weiskirchen, Bruno Christ, Human mesenchymal stem cells towards non-alcoholic steatohepatitis in an immunodeficient mouse model, Experimental Cell Research, 2014, 326, 2, 230

    CrossRef

  13. 13
    Kento Imajo, Masato Yoneda, Yuji Ogawa, Koichiro Wada, Atsushi Nakajima, Microbiota and nonalcoholic steatohepatitis, Seminars in Immunopathology, 2014, 36, 1, 115

    CrossRef

  14. 14
    Badr Alzahrani, Tristan J. Iseli, Lionel W. Hebbard, Non-viral causes of liver cancer: Does obesity led inflammation play a role?, Cancer Letters, 2014, 345, 2, 223

    CrossRef

  15. 15
    Jun Liang, Ying Gong, Yu Wang, QinQin Qiu, Caiyan Zou, LianJun Dou, XueKui Liu, Huaidong Song, Serum Gamma-Glutamyltransferase is Associated with Impaired Fasting Glucose in Chinese Adults: The Cardiometabolic Risk in Chinese (CRC) Study, Cell Biochemistry and Biophysics, 2014, 70, 3, 1823

    CrossRef

  16. 16
    Jeffrey C. Sirota, Kim McFann, Giovanni Targher, Richard J. Johnson, Michel Chonchol, Diana I. Jalal, Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey, Metabolism, 2013, 62, 3, 392

    CrossRef

  17. 17
    Hiroshi Hano, Satoshi Takasaki, Hirohiko Kobayashi, Tomoki Koyama, Tomoe Lu, Keisuke Nagatsuma, In the non-cirrhotic stage of nonalcoholic steatohepatitis, angioarchitecture of portal veins and lobular architecture are maintained, Virchows Archiv, 2013, 462, 5, 533

    CrossRef

  18. 18
    Angelina Mouralidarane, Junpei Soeda, Clara Visconti-Pugmire, Anne-Maj Samuelsson, Joaquim Pombo, Xanthi Maragkoudaki, Adil Butt, Ruma Saraswati, Marco Novelli, Guiseppe Fusai, Lucilla Poston, Paul D. Taylor, Jude A. Oben, Maternal obesity programs offspring nonalcoholic fatty liver disease by innate immune dysfunction in mice, Hepatology, 2013, 58, 1
  19. 19
    Masashi Ninomiya, Yasuteru Kondo, Tooru Shimosegawa, Murine Models of Nonalcoholic Fatty Liver Disease and Steatohepatitis, ISRN Hepatology, 2013, 2013, 1

    CrossRef

  20. 20
    Kento Imajo, Masato Yoneda, Takaomi Kessoku, Yuji Ogawa, Shin Maeda, Yoshio Sumida, Hideyuki Hyogo, Yuichiro Eguchi, Koichiro Wada, Atsushi Nakajima, Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, International Journal of Molecular Sciences, 2013, 14, 11, 21833

    CrossRef

  21. 21
    Elizabeth M. Brunt, Surgical assessment of significant steatosis in donor livers: The beginning of the end for frozen-section analysis?, Liver Transplantation, 2013, 19, 4
  22. 22
    Tao Zheng, Guangwen Shu, Zhanzhan Yang, Shasha Mo, Yin Zhao, Zhinan Mei, Antidiabetic effect of total saponins from Entada phaseoloides (L.) Merr. in type 2 diabetic rats, Journal of Ethnopharmacology, 2012, 139, 3, 814

    CrossRef

  23. 23
    Raúl Jiménez, Elizabeth Hijona, José Emparanza, Jose M. Alústiza, Lander Hijona, Maria T. Macarulla, Maria P. Portillo, Marta Herreros, Adolfo Beguiristain, Juan Arenas, Luis Bujanda, Effect of Neoadjuvant Chemotherapy in Hepatic Steatosis, Chemotherapy, 2012, 58, 2, 89

    CrossRef

  24. 24
    Chang Wook Chon, Bum Soo Kim, Yong Kyun Cho, Ki Chul Sung, Ji Cheol Bae, Tae Wan Kim, Hyun Sun Won, Kwan Joong Joo, Effect of Nonalcoholic Fatty Liver Disease on the Development of Type 2 Diabetes in Nonobese, Nondiabetic Korean Men, Gut and Liver, 2012, 6, 3, 368

    CrossRef

  25. 25
    Kento Imajo, Koji Fujita, Masato Yoneda, Yuichi Nozaki, Yuji Ogawa, Yoshiyasu Shinohara, Shingo Kato, Hironori Mawatari, Wataru Shibata, Hiroshi Kitani, Kenichi Ikejima, Hiroyuki Kirikoshi, Noriko Nakajima, Satoru Saito, Shiro Maeyama, Sumio Watanabe, Koichiro Wada, Atsushi Nakajima, Hyperresponsivity to Low-Dose Endotoxin during Progression to Nonalcoholic Steatohepatitis Is Regulated by Leptin-Mediated Signaling, Cell Metabolism, 2012, 16, 1, 44

    CrossRef

  26. 26
    Shu-zhi Feng, Jian-li Tian, Qiang Zhang, Hui Wang, Ning Sun, Yun Zhang, Bao-yuan Chen, An experimental research on chronic intermittent hypoxia leading to liver injury, Sleep and Breathing, 2011, 15, 3, 493

    CrossRef

  27. 27
    Lionel Hebbard, Jacob George, Animal models of nonalcoholic fatty liver disease, Nature Reviews Gastroenterology & Hepatology, 2011, 8, 1, 35

    CrossRef

  28. 28
    Billur Canbakan, Hakan Senturk, Mustafa Canbakan, Tayfur Toptas, Murat Tuncer, Reliability of caspase activity as a biomarker of hepatic apoptosis in nonalcoholic fatty liver disease, Biomarkers in Medicine, 2011, 5, 6, 813

    CrossRef

  29. 29
    Agnieszka Gornicka, Gareth Morris-Stiff, Samjhana Thapaliya, Bettina G. Papouchado, Michael Berk, Ariel E. Feldstein, Transcriptional Profile of Genes Involved in Oxidative Stress and Antioxidant Defense in a Dietary Murine Model of Steatohepatitis, Antioxidants & Redox Signaling, 2011, 15, 2, 437

    CrossRef

  30. 30
    Anna Wieckowska, Ariel E. Feldstein, Pediatric Gastrointestinal and Liver Disease, 2011,

    CrossRef

  31. 31
    C-F Kuo, K-H Yu, S-F Luo, C-T Chiu, Y-S Ko, J-S Hwang, W-Y Tseng, H-C Chang, H-W Chen, L-C See, Gout and risk of non-alcoholic fatty liver disease, Scandinavian Journal of Rheumatology, 2010, 39, 6, 466

    CrossRef

  32. 32
    Qingyan Liu, David E. Kleiner, Nonalcoholic Steatohepatitis (NASH), Pathology Case Reviews, 2010, 15, 3, 65

    CrossRef

  33. 33
    Yue-Min Nan, Wen-Juan Wu, Na Fu, Bao-Li Liang, Rong-Qi Wang, Liang-Xiao Li, Su-Xian Zhao, Jing-Min Zhao, Jun Yu, Antioxidants vitamin E and 1-aminobenzotriazole prevent experimental non-alcoholic steatohepatitis in mice, Scandinavian Journal of Gastroenterology, 2009, 44, 9, 1121

    CrossRef

  34. 34
    Patrick Ingiliz, Marc-Antoine Valantin, Claudine Duvivier, Fadia Medja, Stephanie Dominguez, Frédéric Charlotte, Roland Tubiana, Thierry Poynard, Christine Katlama, Anne Lombès, Yves Benhamou, Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy, Hepatology, 2009, 49, 2
  35. 35
    Allison Shifflet, George Y. Wu, Non-alcoholic Steatohepatitis: An Overview, Journal of the Formosan Medical Association, 2009, 108, 1, 4

    CrossRef

  36. 36
    Piotr Socha, Andrea Horvath, Pietro Vajro, Piotr Dziechciarz, Anil Dhawan, Hania Szajewska, Pharmacological Interventions for Nonalcoholic Fatty Liver Disease in Adults and in Children: A Systematic Review, Journal of Pediatric Gastroenterology and Nutrition, 2009, 48, 5, 587

    CrossRef

  37. 37
    Yoshihiro Kamada, Tadashi Nakamura, Tohru Funahashi, Miwa Ryo, Hitoshi Nishizawa, Yukiyoshi Okauchi, Juichi Fukushima, Yuichi Yoshida, Shinichi Kiso, Iichiro Shimomura, Norio Hayashi, Visceral Obesity and Hypoadiponectinemia are Significant Determinants of Hepatic Dysfunction, Journal of Clinical Gastroenterology, 2009, 43, 10, 995

    CrossRef

  38. 38
    Robert Rose, Atrayee Banerjee, Shashi K. Ramaiah, Characterization of a lipopolysaccharide mediated neutrophilic hepatitis model in Sprague Dawley rats, Journal of Applied Toxicology, 2007, 27, 6
  39. 39
    Patricio Ibañez, Nancy Solis, Margarita Pizarro, Gloria Aguayo, Ignacio Duarte, Juan Francisco Miquel, Luigi Accatino, Marco Arrese, Effect of losartan on early liver fibrosis development in a rat model of nonalcoholic steatohepatitis, Journal of Gastroenterology and Hepatology, 2007, 22, 6
  40. 40
    Masato Yoneda, Tomoyuki Iwasaki, Koji Fujita, Hiroyuki Kirikoshi, Masahiko Inamori, Yuichi Nozaki, Shiro Maeyama, Koichiro Wada, Satoru Saito, Yasuo Terauchi, Atsushi Nakajima, Hypoadiponectinemia Plays a Crucial Role in the Development of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus Independent of Visceral Adipose Tissue, Alcoholism: Clinical and Experimental Research, 2007, 31,
  41. 41
    P. H. THURAIRAJAH, D. THORBURN, S. HUBSCHER, A. WHITE, W. K. LAI, K. O’DONNELL, D. MUTIMER, Incidence and characterization of serum transaminases elevations in pegylated interferon and ribavirin treated patients with chronic hepatitis C, Alimentary Pharmacology & Therapeutics, 2007, 25, 11
  42. 42
    Roslyn M. London, Jacob George, Pathogenesis of NASH: Animal Models, Clinics in Liver Disease, 2007, 11, 1, 55

    CrossRef

  43. 43
    Dong-Ling Dai, Wei Shen, Hai-Feng Yu, Xiao-Qin Guan, Yong-Fen Yi, Effect of Cordyceps Sinensis on Uncoupling Protein 2 in Experimental Rats with Nonalcoholic Fatty Liver, JOURNAL OF HEALTH SCIENCE, 2006, 52, 4, 390

    CrossRef

  44. 44
    David E. Kleiner, Elizabeth M. Brunt, Mark Van Natta, Cynthia Behling, Melissa J. Contos, Oscar W. Cummings, Linda D. Ferrell, Yao-Chang Liu, Michael S. Torbenson, Aynur Unalp-Arida, Matthew Yeh, Arthur J. McCullough, Arun J. Sanyal, Design and validation of a histological scoring system for nonalcoholic fatty liver disease, Hepatology, 2005, 41, 6
  45. 45
    Z. Xu, L. Chen, L. Leung, T. S. B. Yen, C. Lee, J. Y. Chan, Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia, Proceedings of the National Academy of Sciences, 2005, 102, 11, 4120

    CrossRef

  46. 46
    Anna Wieckowska, Ariel E Feldstein, Nonalcoholic fatty liver disease in the pediatric population: a review, Current Opinion in Pediatrics, 2005, 17, 5, 636

    CrossRef

  47. 47
    Paola Loria, Amedeo Lonardo, Nicola Carulli, Should Nonalcoholic Fatty Liver Disease Be Renamed?, Digestive Diseases, 2005, 23, 1, 72

    CrossRef

  48. 48
    Elizabeth M. Brunt, Brent A. Neuschwander-Tetri, Dana Oliver, Kent R. Wehmeier, Bruce R. Bacon, Nonalcoholic steatohepatitis: Histologic features and clinical correlations with 30 blinded biopsy specimens, Human Pathology, 2004, 35, 9, 1070

    CrossRef

  49. 49
    Chikako Namikawa, Zhang Shu-Ping, John Raynor Vyselaar, Yasuko Nozaki, Yoshihisa Nemoto, Masafumi Ono, Naoaki Akisawa, Toshiji Saibara, Makoto Hiroi, Hideaki Enzan, Saburo Onishi, Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis, Journal of Hepatology, 2004, 40, 5, 781

    CrossRef

  50. 50
    Amedeo Lonardo, Alberto Bagni, Patrizia Tarugi, Paola Loria, The wide spectrum of steatohepatitis, European Journal of Gastroenterology & Hepatology, 2004, 16, 10, 1043

    CrossRef